Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters

Kathleen Williamson, Brian Duggan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose of review
Molecular markers for bladder cancer recurrence and
progression continue to drive many research programmes.
Translating the laboratory findings into the clinical environment
where these markers are used in clinical decision making has
proved problematic. In the clinical arena, stage and grade are
still the main focus for decisions about patient management.
There is however an evolution in bladder cancer research from
single-marker/single-pathway research to a more global
assessment of the tumour cell with DNA microarrays and
proteomics.
Recent findings
In the last year, DNA microarray assessment has revealed
several interesting molecular markers such as p33ING1 and
DEK. Parallel ‘conventional’ single-pathway research has
focused on new novel markers such as HER2/neu, survivin and
matrix metalloproteinase 2 (MMP-2). Molecular markers that
have a long-standing association with bladder cancer
progression such as p53, E-cadherin and Ki-67 have been
reviewed by both single-marker studies and by microarray
studies and their status remains important.
Summary
It is an exciting time in the molecular biology research of bladder
cancer as the focus changes to assess the global genetic and
protein expression within tumour cells. From such a wealth of
information it is likely that molecular markers will make the
translation from benchside to bedside.
Original languageEnglish
Pages (from-to)277-286
JournalCurrent Opinion in Urology
Volume14
Publication statusPublished - 2004

Keywords

  • bladder cancer
  • molecular
  • microarray

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters'. Together they form a unique fingerprint.

  • Cite this